Sponsor:
Beth Israel Deaconess Medical Center
Code:
NCT04603196
Conditions
Multiple Sclerosis
Obstructive Sleep Apnea
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Multiple Sclerosis
Obstructive Sleep Apnea
Study ID
NCT04603196
Start date
Jun 20, 2019
Status verified date
May, 2026
Completion date
Jun 20, 2030
Anticipated
Primary completion date
Jun 20, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
800 participants
Anticipated
Arms
Patients with Multiple Sclerosis with obstructive sleep apnea
Patients with MS without obstructive sleep apnea
Primary outcome measure
Central contacts
Locations
Beth Israel Deaconess Medical Center
Recruiting
Boston, Massachusetts, United States, 02215
Contacts
Principal Investigator:
Jacob Sloane, MD, PhD
Sponsor
Beth Israel Deaconess Medical Center
Last update posted
May 11, 2026
Last verified
May, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Beth Israel Deaconess Medical Center on 2026-05-11.